Related Experiment Video
Updated: Jun 16, 2026

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Repeat CRP measurements and incident myocardial infarction
Daniel Weiner1,2,3, Buu Truong2,3,4, Satoshi Koyama2,3,4
1Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Insights
Persistently elevated C-reactive protein (CRP) indicates a higher risk of myocardial infarction. Repeatedly measuring inflammatory markers like CRP is crucial for accurate cardiovascular risk assessment.
Area of Science:
- Cardiovascular Disease Research
- Inflammation Biomarkers
- Public Health
Background:
- Inflammation is a known risk factor for cardiovascular disease (CVD).
- Understanding the stability of inflammatory markers and their association with myocardial infarction (MI) is critical for risk stratification.
- C-reactive protein (CRP) is a well-established marker of inflammation.
Purpose of the Study:
- To assess the stability of C-reactive protein (CRP) levels over repeated measurements.
- To investigate the association between patterns of repeated CRP measurements and the incidence of first-time myocardial infarction (MI).
Main Methods:
- Analysis of CRP levels in 14,960 UK Biobank participants without diagnosed inflammatory conditions.
- Utilizing Cox proportional hazards models to estimate the association between baseline/repeat CRP and incident MI.
- Examining CRP stability and correlation across a median follow-up interval of 4.4 years.
Main Results:
- Baseline and repeat CRP measurements showed significant correlation (Spearman rho 0.64).
- Persistently elevated CRP (at both baseline and repeat) was significantly associated with increased risk of first-time myocardial infarction (HR = 1.66).
- Elevated CRP at only one time point was not significantly associated with incident MI.
Conclusions:
- Persistently elevated CRP levels are a significant predictor of incident first-time myocardial infarction.
- Repeated measurement of inflammatory markers, such as CRP, is essential for refining cardiovascular risk stratification.
- These findings underscore the clinical utility of monitoring inflammation over time for CVD prevention.
Background:
Inflammation is a causal risk factor for cardiovascular disease. While individuals with elevated levels of inflammation may benefit from targeted therapy, population-level stability of inflammation over time is poorly defined, as is the relationship between repeated measures of inflammatory markers and incident myocardial infarction. C-reactive protein (CRP) is among the best-established inflammatory markers.
Objectives:
To examine (i) the stability of CRP over repeat measurements and (ii) the association between patterns of repeated CRP and rates of first-time myocardial infarction.
Methods:
The relationship between baseline and repeat assessment of CRP was analyzed in 14,960 individuals from the UK Biobank without a diagnosed underlying inflammatory condition. The association between baseline and repeat CRP and first-time myocardial infarction was estimated using a Cox proportional hazards model.
Results:
Among the analyzed cohort, median (IQR) age was 58 (52-63) years, 7,564 (51%) were female, and median (IQR) CRP was 1.1 (0.6-2.3) mg/L at baseline. Baseline and repeat CRP were correlated (Spearman rho 0.64) across a median (IQR) follow-up interval of 4.4 (3.7-4.9) years. Among the 10,566 (71%) individuals with non-elevated CRP (<2 mg/L) at baseline, 8,776 (83%) had non-elevated CRP at repeat, while among the 4,394 (29%) with elevated CRP at baseline, 3,127 (62%) had elevated CRP at repeat. Across median (IQR) follow-up 11.5 (11.4, 11.8) years after the repeat CRP measurement, 426 individuals (2.9%) sustained a first-time myocardial infarction. Relative to non-elevated CRP at baseline and repeat, elevated CRP at both baseline and repeat was associated with incident first-time myocardial infarction (HR = 1.66; 95% CI: 1.31-2.12; P = 3.1 × 10-5), while elevated CRP during only baseline or repeat measurement was not (P > 0.05).
Conclusions:
Persistently elevated CRP was significantly associated with incident first-time myocardial infarction. This finding highlights the importance of repeated measurement of inflammatory markers for cardiovascular risk stratification.
Related Concept Videos
Imaging Studies for Cardiovascular System IV: CMRI
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Cardiomyopathy IV: Restrictive Cardiomyopathy
